Zomedica Corp. (ZOMDF)
OTCMKTS · Delayed Price · Currency is USD
0.1120
-0.0010 (-0.88%)
Nov 26, 2025, 4:00 PM EST
Zomedica Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 29.45 | 27.29 | 25.19 | 18.93 | 4.13 | - | Upgrade | |
Revenue Growth (YoY) | 10.20% | 8.33% | 33.05% | 358.02% | - | - | Upgrade |
Cost of Revenue | 9.4 | 8.2 | 7.87 | 5.46 | 1.08 | - | Upgrade |
Gross Profit | 20.06 | 19.09 | 17.32 | 13.47 | 3.05 | - | Upgrade |
Selling, General & Admin | 43.9 | 46.85 | 43.17 | 32.81 | 22.85 | 8.8 | Upgrade |
Research & Development | 7.67 | 7.27 | 5.74 | 2.58 | 1.58 | 7.96 | Upgrade |
Operating Expenses | 51.57 | 54.12 | 48.91 | 35.39 | 24.43 | 16.76 | Upgrade |
Operating Income | -31.52 | -35.03 | -31.59 | -21.92 | -21.37 | -16.76 | Upgrade |
Interest Expense | - | - | -0.18 | -0 | -0.01 | -0 | Upgrade |
Interest & Investment Income | 2.78 | 3.97 | 5.46 | 2.7 | 0.36 | 0.03 | Upgrade |
Currency Exchange Gain (Loss) | -0.05 | -0.25 | 0.03 | -0.15 | -0.03 | -0.01 | Upgrade |
Other Non Operating Income (Expenses) | -0.11 | 0.01 | -0.09 | -0.01 | 0.05 | 0.01 | Upgrade |
EBT Excluding Unusual Items | -28.89 | -31.31 | -26.38 | -19.38 | -21 | -16.73 | Upgrade |
Impairment of Goodwill | -55.83 | -16.02 | -12.2 | - | - | - | Upgrade |
Gain (Loss) on Sale of Investments | - | - | 2.17 | - | - | - | Upgrade |
Gain (Loss) on Sale of Assets | -0.08 | -0.21 | 0.02 | 0 | -0.25 | -0.18 | Upgrade |
Asset Writedown | - | - | 0.51 | - | - | - | Upgrade |
Other Unusual Items | - | - | - | - | 0.53 | - | Upgrade |
Pretax Income | -84.81 | -47.54 | -35.86 | -19.38 | -20.72 | -16.91 | Upgrade |
Income Tax Expense | -0.29 | -0.56 | -1.33 | -2.37 | -2.33 | - | Upgrade |
Net Income | -84.52 | -46.98 | -34.53 | -17.02 | -18.38 | -16.91 | Upgrade |
Preferred Dividends & Other Adjustments | - | - | - | - | 32.04 | - | Upgrade |
Net Income to Common | -84.52 | -46.98 | -34.53 | -17.02 | -50.42 | -16.91 | Upgrade |
Shares Outstanding (Basic) | 980 | 980 | 980 | 980 | 957 | 364 | Upgrade |
Shares Outstanding (Diluted) | 980 | 980 | 980 | 980 | 957 | 364 | Upgrade |
Shares Change (YoY) | - | - | - | 2.45% | 162.46% | 242.85% | Upgrade |
EPS (Basic) | -0.09 | -0.05 | -0.04 | -0.02 | -0.05 | -0.05 | Upgrade |
EPS (Diluted) | -0.09 | -0.05 | -0.04 | -0.02 | -0.05 | -0.05 | Upgrade |
Free Cash Flow | -22.31 | -28.84 | -27.31 | -14.22 | -14.42 | -16.25 | Upgrade |
Free Cash Flow Per Share | -0.02 | -0.03 | -0.03 | -0.01 | -0.01 | -0.04 | Upgrade |
Gross Margin | 68.10% | 69.95% | 68.76% | 71.15% | 73.89% | - | Upgrade |
Operating Margin | -107.00% | -128.38% | -125.44% | -115.81% | -517.15% | - | Upgrade |
Profit Margin | -286.96% | -172.19% | -137.10% | -89.88% | -1220.01% | - | Upgrade |
Free Cash Flow Margin | -75.74% | -105.71% | -108.45% | -75.12% | -348.97% | - | Upgrade |
EBITDA | -23.43 | -27.04 | -25.29 | -17.88 | -20.24 | -16.23 | Upgrade |
EBITDA Margin | -79.55% | -99.11% | -100.43% | -94.46% | - | - | Upgrade |
D&A For EBITDA | 8.09 | 7.99 | 6.3 | 4.04 | 1.14 | 0.53 | Upgrade |
EBIT | -31.52 | -35.03 | -31.59 | -21.92 | -21.37 | -16.76 | Upgrade |
EBIT Margin | -107.00% | -128.38% | -125.44% | -115.81% | - | - | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.